The AIM Medical Oncology Solution is an oncology benefits management program that promotes evidence-based cancer care. Equipped with value-based reimbursement strategies and AIM Cancer Treatment Pathways, the solution helps your providers deliver affordable care with high efficacy and low toxicity.
types of cancer addressed
treatment agents and medications covered
pathways, covering 95% of chemotherapy costs
Michael J. Fisch, MD, MPH, medical director of our medical oncology programs and genetics, breaks down how our solution finds the best treatment regimens for members with cancer.
Merged seamlessly into provider workflows through the AIM ProviderPortalSM or EMR integration, our automated clinical review process simplifies your providers’ delivery of evidence-based care. It can identify the most appropriate care for your members or direct your providers to a peer-to-peer conversation with our physicians.
Streamline provider requests
Enables providers to easily submit requests for care online
Gain clinical assurance
Autoreviews the request for clinical appropriateness, using clinical criteria, your policy, or both.
Clinicians are available for cases that do not meet clinical criteria
Prioritize evidence-based care
Directs care to the right test, treatment, or setting
Close the loop
Integrates with your technology for claims, care management, and reporting
An experienced team of physicians and nurses lead and support our Medical Oncology Solution. Their expertise across numerous clinical specialties expands your organization’s clinical brainpower and acumen immediately. It also reinforces your clinical credibility and accelerates acceptance among your providers.
Michael Fisch, MD, serves as Medical Director of Medical Oncology Programs and Genetics for AIM. In his role, he works closely with the executive leadership team to provide clinical expertise for the expansion of the AIM Medical Oncology Solution and for the AIM Genetic Testing Solution.Read More about Dr. Fisch
Stacey Ban, MD, serves as the Vice President and Medical Director for the AIM Medical Oncology Solution. She provides front line clinical expertise including the development of AIM Cancer Treatment Pathways. She played an important role leading the clinical process during the implementation of our solutions for Medical Oncology and Radiation Therapy.Read More about Stacey Ban
The influences that can deter evidence-based care
Our team, standards, and approach support better care for cancer patients
It's the fundamental linchpin to them
Clinical integrity, flexibility, and practice-wide training lead to appreciation and relief